Rajdev All News
Wednesday, December 26, 2018
Merck KGaA-Pfizer to end late-stage ovarian cancer treatment study
Merck KGaA and Pfizer Inc said on Friday they were ending a late-stage study for their drug to treat a form of ovarian cancer in previously untreated patients.
from Reuters: Health https://reut.rs/2EDPQRu
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment